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Abstract
Background:  The rapid completion of genome sequences has created an infrastructure of
biological information and provided essential information to link genes to gene products, proteins,
the building blocks for cellular functions. In addition, genome/cDNA sequences make it possible to
predict proteins for which there is no experimental evidence. Clues for function of hypothetical
proteins are provided by sequence similarity with proteins of known function in model organisms.
Results:  We constructed a two-dimensional protein map and searched for expression of
hypothetical proteins in rat brain. Two-dimensional electrophoresis (2-DE) with subsequent in-gel
digestion of spots and matrix-assisted laser desorption/ionization  (MALDI) spectrometric
identification were applied. In total about 3700 spots were analysed, which resulted in the
identification of about 1700 polypeptides, that were the products of 190 different genes. A number
of hypothetical gene products were detected (30 of 190, 15.8%) and are considered brain proteins.
Conclusions: A major finding of this study is the demonstration of the existence of putative
proteins that were so far only deduced from their nucleic acid structure by a protein chemical
method independent of antibody availability and specificity and unambiguously identifying proteins.
Background
The amount of genome sequence data now available is
enormous, with only more to come. At this time, sequenc-
ing of more than 700 genomes is either finished or in
progress, and results may be found in various public data-
bases [1]. With the availability of genome sequences,
increasing attention has focused on identifying the com-
plete set of mammalian genes, both protein-coding and
non-protein-coding. As various analyses [2,3] have
revealed, different annotation criteria lead to different sets
of predicted genes, and even the true number of protein-
coding genes remains uncertain. Biases in the training sets
used for optimizing gene-finding algorithms lead to sys-
tematic biases in the types of genes that are predicted com-
putationally and so important genes and gene classes can
be missed.
A draft sequence of the mouse genome and comparative
analyses with the human sequence has been published
[4]. The sequencing of the rat genome is also well
advanced (see "Rat Genome Database: Sequences" at
http://rgd.mcw.edu/sequences/rgp_info.shtml). Compar-
ative genomics studies have shown that many genes con-
tributing to human disease are conserved among these
genomes, underscoring the utility to biomedical research
of studies in these species [5,6]. Comparative human and
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mouse sequence analyses have supported the notion that
there are only about 30000 genes in a typical mammalian
genome and confirmed that, on average, rodent and
human genes are about 85% identical in their coding
sequences [4,7]. The mouse and rat model systems have
several advantages over higher mammals for the investiga-
tion of mammalian biology. In both species, there are
numerous genetically well-defined lines that differ from
each other in phenotypic characteristics and their compo-
sition of genetic variants. This, coupled with their modest
cost maintenance and short generation times, has under-
pinned an explosion of studies in genetic mapping and
the development of genetic manipulation tools over the
past decades. Moreover, a very broad range of phenotypic
assays can be applied to both model organisms allowing
for the acquisition of precise data on both qualitative and
quantitative traits. Taken together, these developments
have driven the utility of the mouse and rat for studies of
mammalian physiology, biochemistry and development
and the study of genes and genetic pathways involved in
genetic disease. Although the mouse is the primary organ-
ism for studies of mammalian genetics and development,
and is seeing increased use for several researches, the rat
has been used more frequently for physiological and
pharmacological studies [8].
Proteomics methods, relying on integration of significant
advances recently achieved in two-dimensional (2-D)
electrophoretic separation of proteins and mass spectrom-
etry (MS), are essential for studying protein expression,
activity, regulation and modifications. Genomics coupled
to with proteomics represents now important tools and
high throughput methods are in use for analysing gene
and protein expression, discovering new gene or protein
products, and understanding of gene and protein func-
tions including post-genomic studies. Therefore, the sig-
nificance of informatics in proteomics will gradually
increase because of the advent of high-throughput meth-
ods relying on powerful data analysis. Recently, we have
applied proteomics in the study of human and rat brain
[9]. In rats, we analysed brains of animals serving as mod-
els of human diseases such as anxiety and perinatal
asphyxia (unpublished data) and of animals treated with
the toxic agent kainic acid [10,11].
Although gene prediction programs have become more
accurate and sensitive, analysis of proteins provides more
reliable evidence for existence and function of predicted
proteins. To allow insight into whether they are expressed
in brain or not, we constructed a two-dimensional protein
map by applying 2-DE coupled to matrix-assisted laser
desorption ionization-mass spectroscopy (MALDI-MS) in
rat brain and identified 30 hypothetical proteins.
Results
2-DE analysis
Rat brain proteins were solubilised in the IEF-compatible
reagents urea, thiourea and CHAPS and analysed by 2-D
gels. The 2-DE separation was performed on broad pH
range IPG strips and protein spots were visualised follow-
ing staining with colloidal Coomassie blue. A large series
of proteins were successfully identified, including hypo-
thetical proteins. A representative gel presenting hypo-
thetical proteins is shown in Fig. 1.
Protein identification
Proteins were identified by MALDI-MS on the basis of
peptide mass matching [12], following in-gel digestion
with trypsin. The spots of each gel were selected randomly
with the goal of detecting as many new gene products as
possible. Each excised spot was analysed individually. The
peptide masses were matched with the theoretical peptide
masses of all known proteins from all species. In total
about 3700 spots were analysed, resulting in the identifi-
cation of about 1700 polypeptides that were the products
of 190 different genes. Most proteins identified in the
present study were overlapping with previous data
obtained by using enriched cellular subfractions and pre-
electrophoretic chromatographical separation of brain
homogenates [13] and only predicted structures were
included to prevent double – documentation. Thirty of
190 gene products were hypothetical or poorly described
gene products. Some of them were represented by strong
spots and the present study shows that they are indeed
expressed in rat brain. In Table 1 – see additional file 1,
data for hypothetical protein identification and assign-
ment are provided including peptide matches, probability
of assignment of random identity, theoretical/observed pI
and molecular weight values. Some of the identified
hypothetical proteins showed heterogeneity and were rep-
resented on 2-DE gel by more than one spot (Fig 1). In
average, approximately 2–3 spots corresponded to one
hypothetical protein. For example, hypothetical 79.7 kDa
protein (Q91VD9) was represented by five spots, with dif-
ferent pI, probably reflecting post-translational modifica-
tions (PTMs) (Fig 1).
Predicted function of hypothetical proteins
Most nucleic acid sequences of hypothetical proteins were
directly submitted to the GenBank/EMBL/DDBJ database.
Based on the assumption that sequence-domain similari-
ties reflect functional relationship, it may be predicted
how hypothetical proteins play a role in biological mech-
anism. The sequences of hypothetical proteins were sub-
mitted to BLAST search. Putative conserved domains and
identity to know protein were obtained by sequence sim-
ilarity (Conserved Domain Database, http://
www.ncbi.nlm.nih.gov/BLAST) (Table 1 – see additional
file 1). A hypothetical protein showing one or moreProteome Science 2004, 2 http://www.proteomesci.com/content/2/1/1
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2-DE gel image of rat brain proteins depicting identified 30 hypothetical proteins Figure 1
2-DE gel image of rat brain proteins depicting identified 30 hypothetical proteins. Accession numbers are given. Brain proteins 
were extracted and separated on an immobilised pH 3–10 non-linear gradient strip followed by separation on a 9–16% gradient 
polyacrylamide gel. The gel was stained with Coomassie blue and spots were analysed by MALDI-MS.
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Graphical view of domains of two hypothetical proteins; Homo sapiens sequence 42 from patent wo0222660 and Homo sapi- ens sequence 33 from patent wo0218424 Figure 2
Graphical view of domains of two hypothetical proteins; Homo sapiens sequence 42 from patent wo0222660 and Homo sapi-
ens sequence 33 from patent wo0218424.
Alignment of 1700082C19Rik protein (Q9D9F6) with homologs Figure 3
Alignment of 1700082C19Rik protein (Q9D9F6) with homologs. Alignments were constructed using the CLUSTALW program 
http://clustalw.genome.ad.jp. Multiple sequence alignment with CLUSTALW showed that 1700082C19Rik protein has 97.4% 
similarity to N-termial region of inner membrane, mitochondrial (IMMT_MOUSE, Q8CAQ8), 93.8% similarity to N-terminal 
region of IMMT_HUMAN (Q16891), and 34.9% similarity to N-terminal region of IMMT_DROME (Q91928).
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significant structural homologs, is predicted to have
molecular properties similar to the homologs. Putative
cellular localisations of hypothetical proteins were inves-
tigated by PSORT II http://www.psort.org using of k-near-
est neighbour (k-NN) algorithm for assessing the
probability of localising at each candidate sites. Hypothet-
ical proteins may be localised in cytoplasm (16 of 30, 53.3
%), mitochondria (9 of 30, 30 %) and nuclear (5 of 30,
16.7 %) (data not shown). Hypothetical proteins were
divided into several groups by putative function (Table 1
– see additional file 1). For five hypothetical proteins
("Unknown" in Table 1), poor information on predicted
domains and function was available in data banks includ-
ing SWISS-PROT database. Therefore, we performed
BLAST search (NCBI, http://www.ncbi.nlm.nih.gov) that
predicted domains of two proteins, Homo sapiens
sequence 42 from patent wo0222660 and Homo sapiens
sequence 33 from patent wo0218424 (Fig 2). Homo sapi-
ens sequence 42 from patent wo0222660 (CAD34734)
was detected in 2-DE gels as two spots with different pI,
probably reflecting PTMs or isoforms (Fig. 1). This protein
has 455 amino acid residues according to patent cDNA
sequence (HYSEQ. INC, USA) and belongs to TufB family
(Fig 2). Homo sapiens sequence 33 from patent
wo0218424 (CAD33306) was resolved as four spot (Fig.
1) and consists of 429 amino acid residues. The protein
has never been described in literature and is categorised as
GTP/CDC (guanosine triphosphate/cell division control)
family including CDC 3, CDC 10, CDC 11, CDC 12/Sep-
tin and some uncharacterised proteins involved in cytoki-
nesis http://www.sanger.ac.uk/Pfam/ (Fig 2). Although
members of this family are involved in cell division and
bind GTP, biological roles of these proteins are unclear.
To predict the function of 5730568A12Rik protein,
1700082C19Rik protein, and 1700021B03Rik protein,
we searched for homologs of these proteins through bio-
informatic tools (ProteinPredict, http://www.embl-hei
delberg.de/predictprotein/) and performed the CLUS-
TALW multiple sequence alignments. The homologs of
5730568A12Rik protein (Q9CXS1) were identified from
C. elegans (Q23344, hypothetical 34.0 kDa protein, puta-
tive serine/threonine protein phosphatase) to H. sapiens
(Q96ER9, similar to 5730568A12Rik protein) and this
finding suggests that 5730568A12Rik protein may play an
important role in cell biology (data not shown). However,
the putative function of 5730568A12Rik protein is still
unknown. According to BLAST searching results,
1700082C19Rik protein (Q9D9F6) shows high homol-
ogy with mitochondrial inner membrane protein (Fig 3)
and 1700021B03Rik protein (Q9DA45) belongs to DUF
737 family containing uncharacterised protein.
Discussion
Herein we identify hypothetical proteins in rat brain pre-
dicted from nucleic acid sequences and show that these
proteins exist and are indeed expressed in rat brain. This
observation adds structures to the list of proteins of
metabolism, cytoskeleton, chaperone system, cell divi-
sion/differentiation machinery and proteolysis.
The group of hypothetical proteins related to metabolism
is the largest protein class (Table 1 – see additional file 1)
and is strongly represented in rat brain map. Hypothetical
proteins with enzymatic activity identified by proteomics
in the rat brain may be useful for determination of
metabolic disorders in the brain, including inborn errors
of metabolism but also form the basis for physiological or
pharmaceutical studies. We are complementing
metabolism related proteins by describing new members
of intermediary metabolism, hydrolytic enzymes and oxi-
doreductases. We furthermore add a dynamin-1-like, an
erythrocyte membrane protein-like, an actin related pro-
tein 1-like and a tubulin alpha-2-like protein to cytoskel-
eton proteins. The KIAA0417 gene, never reported in the
human system before as well as ATP and nucleotide bind-
ing TOB3 were assigned to chaperone system in humans.
New members of cell division and differentiation systems
were represented by the hypothetical protein FLJ38330
and CDCrel-1A.
As to proteins of the category "unknown" function,
according to analysis by searching conserved domains in
NCBI database http://www.ncbi.nlm.nih.gov, homo sapi-
ens sequence 42 from patent wo0222660 has a conserved
domain; TufB, GTPases-translation elongation factors
[translation, ribosomal structure and biogenesis] (Fig. 2).
Elongation factor Tu (EF-Tu) belongs to the family of GTP
binding proteins and the function of EF-Tu is to bind ami-
noacyl-tRNA (aa-tRNA) and GTP to form a stable ternary
complex that interacts with the A site of the mRNA-pro-
grammed ribosome. In addition, EF-Tu is involved in sev-
eral mechanisms, such as replication, transcription, RNA
processing, DNA repair, regulation of translation, malig-
nant transformation, and regulation of development [14].
EF-1a (the eukaryotic counterpart of EF-Tu) binds to actin
filaments and influences assembly of cytoskeletal poly-
mers [15-17]. Additionally EF-1a apparently participates
in the degradation of N-terminally blocked proteins by
the 26S proteasome [18]. In recent years, it has been
shown that EF-Tu has chaperone-like properties in protein
folding [19,20] and EF-Tu displays protein disulfide iso-
merase activity [21]. Molecular chaperones form a class of
polypeptide binding proteins that are implicated in pro-
tein folding, protein targeting to membranes, protein
renaturation or degradation after stress, and the control of
protein-protein interactions.
Homo sapiens sequence 33 from patent wo0218424 is
classified as GTP_CDC (Fig 2) and presents with a coiledProteome Science 2004, 2 http://www.proteomesci.com/content/2/1/1
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coil region and may be regulated by cyclic AMP. Although
members of this family are involved in cell division and
bind GTP, biological roles of these proteins are unclear.
1700082C19Rik protein shows high homology with
mitochondrial inner membrane protein and this protein
may well be assigned to mitochondrial structure in the
mammalian system in particular as homologues of
1700082C19Rik protein containing a mitochondrial
signal and found in several organisms at the nucleic acid
level, reveal high levels of similarity to this protein.
1700021B03Rik protein belongs to the DUF 737 family
containing uncharacterised protein (Fig 4). According to
alignment analysis by the Pfam program http://
www.sanger.ac.uk, eleven proteins including
1700021B03Rik protein were assigned DUF 737 family
members and these members just belong to high mam-
malian species such as mouse, monkey, and human (data
not shown). Although this finding suggests that
1700021B03Rik protein may be related to development
of brain in the mammalian system, the role of this protein
is still unclear.
Some of hypothetical proteins were detected in mouse
hippocampus, human mesothelial, lymphocyte and
bronchial cell lines (Table 1 – see additional file 1). None
of the listed hypothetical proteins were observed in
human brain maps [22,23] or in a previously published
rat map [24].
A number of hypothetical proteins encoded in sequenced
rat genome have computationally recognized homology
to at least one well-characterised domain, but functional
interpretation of these proteins is limited. In addition,
functional changes over evolutionary time [25,26] and
database errors [27] confound reliable computational
prediction of the precise functions of newly discovered
genes. Absence of experimental evidence makes it difficult
to directly ascertain their molecular role.
Conclusions
In the present study, we identified a number of so far
hypothetical gene products, which may be considered as
tentative brain proteins. The major finding of this study is
the evidence for existence of putative protein proposed to
exist from its nucleic acid structure in 2-DE rat brain and
providing the tool for unambiguous analysis of these
structures [28,29].
Methods
Rat brain samples
The animal studies were conducted according to the
guidelines of the American Physiological Society. Rats,
male and 8 days old, were sacrificed for the experiments
by decapitation and pooled. Whole brains were kept at -
80°C until biochemical assays were performed. The freez-
ing chain was never interrupted until use. Experiments
were carried out in triplicate.
Representative DUF 737 family proteins, including 1700021B03Rik protein (Q9DA45) Figure 4
Representative DUF 737 family proteins, including 1700021B03Rik protein (Q9DA45).
Hypothetical protein
FLJ20420
(Human, Q9NX63)
1700021B03Rik
(Mouse, Q9DA45)
227 residues
258 residues
0610041L09Rik
(Mouse, Q9CRB9)
212 a.a
14 a.a 175 a.a
227 residues
14 a.a 175 a.a
coiled coil
DUF 737
DUF 737
DUF 737
1 a.aProteome Science 2004, 2 http://www.proteomesci.com/content/2/1/1
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Two-dimensional gel electrophoresis (2-DE)
Brain tissue was suspended in 1 ml of sample buffer con-
sisting of 40 mM Tris, 5 M urea (Merck, Darmstadt, Ger-
many), 2 M thiourea (Sigma, St. Louis, MO, USA), 4%
CHAPS (3-[(3-cholamidopropyl) dimethylammonio]-1-
propane-sulfonate) (Sigma), 10 mM 1,4-dithioerythritol
(Merck), and 1 mM EDTA (ethylenediaminetetraacetic
acid) (Merck), a mixture of protease inhibitors, 1 mM
phenylmethylsulfonyl chloride, and 1 µg of each pepsta-
tin A, chymostatin, leupeptin, and antipain. The suspen-
sion was sonicated for approximately 30 sec and
centrifuged at 150,000 g for 45 min. The protein content
in the supernatant was determined by the Coomassie blue
method [30]. 2-DE was performed essentially as reported
[31]. Samples of 1 mg protein were applied on immobi-
lised pH 3–10 non-linear gradient strips. Focusing started
at 200 V and the voltage was gradually increased to 5000
V at 3 V/min and kept constant for a further 24 h (approx-
imately 180,000 Vh totally). The two-dimensional separa-
tion was performed on 9–16% gradient sodium dodecyl
sulfate polyacrylamide gels. The gels (180 × 200 × 1.5
mm) were run at 40 mA per gel. After protein fixation for
12 h in 50% methanol, containing 10% acetic acid, the
gels were stained with colloidal Coomassie blue (Novex,
San Diego, CA, USA) for 5 h. Molecular masses were deter-
mined by running standard protein markers (Bio-Rad
Laboratories, Hercules, CA) covering the range 10–250
kDa. pI values were used as given by the supplier of the
immobilised pH gradient strips (Amersham Bioscience,
Uppsala, Sweden). Excess of dye was washed out from the
gels with distilled water and the gels were scanned with
ImageScanner (Amersham Bioscience).
Matrix-associated laser desorption/ionization mass 
spectrometry (MALDI-MS)
MALDI-MS analysis was performed as described else-
where [31,32] with minor modifications. Spots were
excised with a spot picker and placed into 96-well micro-
titer plates. Each spot was destained with 100 µl of 30%
acetonitrile in 50 mM ammonium bicarbonate and dried
in a speedvac evaporator. Each dried gel piece was rehy-
drated with 4 µl of 3 mM Tris-HCl, pH 9.0, containing 50
ng trypsin (Promega, Madison, WI, USA). After 16 h at
room temperature, 7 µl of distilled water were added to
each gel piece and samples were shaken for 10 min. Four
µl of 50% acetonitrile; containing 0.3% trifluoroacetic
acid and the standard peptides, des-Arg-bradykinin
(Sigma, 904.4681 Da), and adrenocorticotropic hormone
fragment 18–39 (Sigma, 2465.1989 Da); were added to
each gel piece and shaken for 10 min. Sample application
was performed using SymBiot I sample processor (PE Bio-
systems, Framingham, MA, USA). 1.5 µl of the peptide
mixture were simultaneously applied on 1 µl of matrix,
consisting of a saturated solution of α-cyano-4-hydroxy-
cinnamic acid (Sigma) in 50% acetonitrile, containing
0.1% trifluoroacetic acid. Samples were analysed in a
time-of-flight mass spectrometer (Reflex 3, Bruker Analyt-
ics, Bremen, Germany). An accelerating voltage of 20 kV
was used. Peptide matching and protein searches were
performed automatically. Peptide masses were compared
with the theoretical peptide masses of all available pro-
teins from all species. Monoisotopic masses were used
and a mass tolerance of 0.0025% was allowed. The algo-
rithm used for determining the probability of a false pos-
itive match with a given MS-spectrum is described
elsewhere [33].
Prediction of hypothetical protein function
Based on MALDI-MS analysis, we identified hypothetical
proteins and their sequences were applied to diverse data-
bases, including SWISS-PROT and NCBI. Amino acid
sequences of proteins without available information on
putative function were aligned with homologs by CLUS-
TALW Multiple Sequence Alignments program obtained
from the Web http://clustalw.genome.ad.jp.
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Table 1 – Hypothetical proteins in rat brain and their putative functions. 
Rat proteins were separated by 2-DE and identified by MALDI-MS, fol-
lowing in-gel digestion with trypsin. The spots representing the identified 
proteins are indicated in Fig 1 and are designated with their accession 
numbers of SWISS-PROT or the other database http://
www.ncbi.nlm.nih.gov. The theoretical/observed molecular weight (MW) 
and pI values, as well as the number of matching peptides (matches) and 
the probability of assignment (pMism) are given. Some hypothetical pro-
teins were detected in mouse hippocampus
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